alloxan has been researched along with diosmin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bodinier, MC; Jean, T | 1 |
| Ahmed, A; Ahmed, S; Bolshette, N; Borgohain, M; Chowdhury, L; Kwatra, M; Lahkar, M; Mundhe, N | 1 |
2 other study(ies) available for alloxan and diosmin
| Article | Year |
|---|---|
Mediators involved in inflammation: effects of Daflon 500 mg on their release.
Topics: Alloxan; Animals; Anti-Inflammatory Agents; Blood Glucose; Diabetes Mellitus, Experimental; Diosmin; Drug Combinations; Flavonoids; Free Radicals; Granuloma; Hesperidin; Humans; Inflammation; Kidney Glomerulus; Macrophages; Mice; Neutrophils; Permeability; Prostaglandins; Rats; Thromboxane B2 | 1994 |
Diosmin Modulates the NF-kB Signal Transduction Pathways and Downregulation of Various Oxidative Stress Markers in Alloxan-Induced Diabetic Nephropathy.
Topics: Alloxan; Animals; Cytokines; Diabetic Nephropathies; Diosmin; Down-Regulation; Hyperglycemia; Hypoglycemic Agents; NF-kappa B; Oxidative Stress; Rats; Rats, Wistar; Signal Transduction | 2016 |